Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EDIT Editas Medicine, Inc.

交易中 07-22 09:32:25 EDT

5.01

+0.01

+0.20%

最高5.08	最低5.01	成交量4.32万
今开5.08	昨收5.00	日振幅1.40%
总市值4.12亿	流通市值3.83亿	总股本8,224万
成交额21.90万	换手率0.06%	流通股本7,641万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine, Inc.","latestPrice":5.01,"timestamp":1721655141947,"preClose":5,"halted":0,"volume":43195,"delay":0,"floatShares":76411290,"shares":82237974,"eps":-2.102471,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"07-22 09:32:25 EDT","open":5.08,"high":5.08,"low":5.01,"amount":219046.916093,"amplitude":0.014,"askPrice":5.02,"askSize":1,"bidPrice":5,"bidSize":2872,"shortable":3,"etf":0,"ttmEps":-2.102471,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":5,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.08,"preClose":5,"latestTime":"09:29 EDT","volume":931,"amount":4763.2598454,"timestamp":1721654970002},"postHourTrading":{"tag":"盘后","latestPrice":5.1,"preClose":5,"latestTime":"19:57 EDT","volume":21119,"amount":106294.28,"timestamp":1721433467244},"volumeRatio":2.968266,"impliedVol":1.0951,"impliedVolPercentile":0.9004},"requestUrl":"/m/hq/s/EDIT","defaultTab":"news","newsList":[{"id":"2452713405","title":"Editas Medicine, Inc.盘中异动 股价大跌5.00%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452713405","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452713405?lang=zh_cn&edition=full","pubTime":"2024-07-20 00:21","pubTimestamp":1721406102,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日00时21分，Editas Medicine, Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报5.04美元/股，成交量51.0688万股，换手率0.62%，振幅5.28%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002142af933328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240720002142af933328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2452436588","title":"Editas Medicine, Inc.盘中异动 急速下跌5.07%报5.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436588","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452436588?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:39","pubTimestamp":1721317143,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时39分，Editas Medicine, Inc.股票出现异动，股价急速下挫5.07%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2190.82%、1810.55%、1167.10%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718233904941f85ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718233904941f85ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2452157443","title":"Editas Medicine, Inc.盘中异动 大幅下挫5.35%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452157443","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452157443?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:31","pubTimestamp":1721223115,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时31分，Editas Medicine, Inc.股票出现波动，股价快速跳水5.35%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Aditxt, Inc.、Longeveron Inc.、Aptevo Therapeutics Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为660.48%、474.25%、100.10%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Aditxt, Inc.、Seres Therapeutics, Inc.，振幅分别为13.22%、13.13%、10.63%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213155941f7e43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213155941f7e43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2451918301","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451918301","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451918301?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:56","pubTimestamp":1721138181,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时56分，Editas Medicine, Inc.股票出现异动，股价快速拉升5.17%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1740.34%、985.26%、93.40%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.19%、39.04%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162156219681d333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162156219681d333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2450311115","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.12%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450311115","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450311115?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:30","pubTimestamp":1720794649,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时30分，Editas Medicine, Inc.股票出现波动，股价急速上涨5.12%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为2436.38%、89.63%、44.29%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为147.88%、48.15%、47.50%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122230509681c68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122230509681c68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2450436340","title":"Editas Medicine, Inc.盘中异动 快速上涨5.12%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450436340","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450436340?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:34","pubTimestamp":1720704871,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时34分，Editas Medicine, Inc.股票出现波动，股价快速拉升5.12%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为264.93%、191.40%、176.99%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.，振幅分别为31.43%、22.94%、15.15%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213432aef93d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213432aef93d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2450443086","title":"Editas Medicine, Inc.盘中异动 股价大涨5.01%报4.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450443086","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450443086?lang=zh_cn&edition=full","pubTime":"2024-07-09 01:51","pubTimestamp":1720461063,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日01时51分，Editas Medicine, Inc.股票出现异动，股价快速拉升5.01%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为5319.21%、205.35%、178.57%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Annovis Bio, Inc.，振幅分别为121.11%、83.58%、56.04%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090151049681ab3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090151049681ab3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2445902074","title":"Editas Medicine, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445902074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445902074?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:32","pubTimestamp":1719235920,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时32分，Editas Medicine, Inc.股票出现波动，股价急速拉升5.09%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Revelation Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药涨幅较大，Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为316.03%、43.37%、33.15%，振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、G1 Therapeutics, Inc.，振幅分别为21.33%、11.62%、10.20%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213201aef650d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213201aef650d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2443381636","title":"Editas Medicine, Inc.盘中异动 急速下挫5.05%报5.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443381636","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443381636?lang=zh_cn&edition=full","pubTime":"2024-06-14 00:30","pubTimestamp":1718296230,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日00时30分，Editas Medicine, Inc.股票出现异动，股价急速下挫5.05%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大，Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2358.50%、1253.32%、134.78%，振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为102.21%、82.05%、74.62%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614003030aef4d803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614003030aef4d803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2442552818","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.52%报5.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552818","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442552818?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199167,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，Editas Medicine, Inc.股票出现异动，股价急速上涨5.52%。截至发稿，该股报5.73美元/股，成交量9.0135万股，换手率0.11%，振幅1.57%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122132479f352b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406122132479f352b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2440123973","title":"Editas Medicine, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440123973","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440123973?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:16","pubTimestamp":1717510560,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时16分，Editas Medicine, Inc.股票出现波动，股价急速上涨5.08%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、天境生物涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为57.02%、38.37%、32.32%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、31.22%、28.08%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221600af8bef95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221600af8bef95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2439473296","title":"Editas Medicine Inc：Evercore ISI将目标价格从15美元下调至7美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439473296","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439473296?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:27","pubTimestamp":1717075645,"startTime":"0","endTime":"0","summary":"Editas Medicine Inc：Evercore ISI将目标价格从15美元下调至7美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530212740957a9626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530212740957a9626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","EVR"],"gpt_icon":0},{"id":"2439527026","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.08%报5.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439527026","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439527026?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:43","pubTimestamp":1716990219,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时43分，Editas Medicine, Inc.股票出现异动，股价急速下跌5.08%。截至发稿，该股报5.05美元/股，成交量16.313万股，换手率0.20%，振幅3.21%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292143399681085a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405292143399681085a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2439586302","title":"Editas Medicine, Inc.盘中异动 快速下挫5.12%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439586302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439586302?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:52","pubTimestamp":1716918739,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时52分，Editas Medicine, Inc.股票出现波动，股价快速下跌5.12%。截至发稿，该股报5.34美元/股，成交量92.781万股，换手率1.13%，振幅7.99%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529015220aef21f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529015220aef21f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2437299804","title":"Editas Medicine, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437299804","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437299804?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:53","pubTimestamp":1716386031,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时53分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.08%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522215351aef1183a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522215351aef1183a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2436607599","title":"Editas Medicine, Inc.2024财年第一财季实现净利润-61.95百万美元，同比减少26.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436607599","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436607599?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:22","pubTimestamp":1715876544,"startTime":"0","endTime":"0","summary":"3月31日，Editas Medicine, Inc.公布财报，公告显示公司2024财年第一财季净利润为-61.95百万美元，同比减少26.33%；其中营业收入为1.14百万美元，同比减少88.43%，每股基本收益为-0.76美元。从资产负债表来看，Editas Medicine, Inc.总负债1.46亿美元，其中短期债务12.36百万美元，资产负债比为3.02，流动比率为0.05。机构评级：截至2024年3月31日，当前有14家机构对Editas Medicine, Inc.目标价做出预测，其中目标均价为14.79美元，其中最低目标价为7.00美元，最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517002228877138e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240517002228877138e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT"],"gpt_icon":0},{"id":"2435190725","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.08%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435190725","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435190725?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:30","pubTimestamp":1715693456,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时30分，Editas Medicine, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报6.00美元/股，成交量5.8285万股，换手率0.07%，振幅1.58%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305779279e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305779279e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2435637315","title":"Editas Medicine, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435637315","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435637315?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:32","pubTimestamp":1715607160,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时32分，Editas Medicine, Inc.股票出现波动，股价急速上涨5.45%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Ac Immune Sa、Nutriband Inc C/Wts 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Reneo Pharmaceuticals, Inc.较为活跃，换手率分别为22.77%、15.56%、13.62%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa，振幅分别为26.92%、13.20%、10.82%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132132407a599a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132132407a599a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2434898829","title":"Editas Medicine, Inc.盘中异动 下午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434898829","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434898829?lang=zh_cn&edition=full","pubTime":"2024-05-11 02:32","pubTimestamp":1715365951,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日02时32分，Editas Medicine, Inc.股票出现异动，股价大幅跳水5.04%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102323279270bd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102323279270bd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2433295107","title":"Editas Medicine, Inc.盘中异动 股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433295107","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433295107?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:32","pubTimestamp":1715175136,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时32分，Editas Medicine, Inc.股票出现波动，股价快速跳水5.90%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Repare Therapeutics Inc.、Adaptive Biotechnologies Corporation、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为199.11%、25.00%、10.63%，振幅较大的相关个股有Veru Inc.、Adaptive Biotechnologies Corporation、Rani Therapeutics Holdings, Inc.，振幅分别为9.20%、8.68%、8.58%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132178ae8dd52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132178ae8dd52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.editasmedicine.com","stockEarnings":[{"period":"1week","weight":-0.0975},{"period":"1month","weight":-0.0079},{"period":"3month","weight":-0.0893},{"period":"6month","weight":-0.382},{"period":"1year","weight":-0.4299},{"period":"ytd","weight":-0.5064}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立，后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司，致力于通过纠正患者的致病基因治疗与基因相关的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.061207},{"month":2,"riseRate":0.375,"avgChangeRate":0.022799},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.0355},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.074249},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.003432},{"month":6,"riseRate":0.555556,"avgChangeRate":0.068829},{"month":7,"riseRate":0.666667,"avgChangeRate":0.01412},{"month":8,"riseRate":0.625,"avgChangeRate":0.080833},{"month":9,"riseRate":0.125,"avgChangeRate":-0.128196},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040926},{"month":11,"riseRate":0.625,"avgChangeRate":0.144442},{"month":12,"riseRate":0.375,"avgChangeRate":0.101676}],"exchange":"NASDAQ","name":"Editas Medicine, Inc.","nameEN":"Editas Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Editas Medicine, Inc.,EDIT,Editas Medicine, Inc.股票,Editas Medicine, Inc.股票老虎,Editas Medicine, Inc.股票老虎国际,Editas Medicine, Inc.行情,Editas Medicine, Inc.股票行情,Editas Medicine, Inc.股价,Editas Medicine, Inc.股市,Editas Medicine, Inc.股票价格,Editas Medicine, Inc.股票交易,Editas Medicine, Inc.股票购买,Editas Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}